Latest blog articles
-
On 16 July 2020, the Court of Justice (Court) handed down its judgment on the long-anticipated Schr
-
A few weeks ago, I predicted on this blog that 16 July 2020 would be the most important day of the year, for privacy professionals, because of
-
The ongoing COVID-19 pandemic is arguably one of the biggest crises of modern times. The conflict between the search for a vaccine, and the artificial scarcity created by patent law, has created a catch-22 situation. How will patent law apply to a vaccine under these circumstances?
-
During the European Council this week all eyes are, again, on the negotiations for the future European Union (EU) budget. Analysts tended to focus mainly on two things.
-
After an exhausting few months in the ‘COVID-19 era’—as we can call it now—after months of hard work and the stress of dealing with a pandemic, everybody is looking to take a break during the summer.
-
-
Several pharmaceutical companies all around the world, including in the European Union (EU), have been racing to find a treatment for the virus. Since these may be subject to patent rights, government intervention may be needed.
-
Maastricht University’s cross-syllabus approach could point the way forward, say Herco Fonteijn and Teun Dekker.
Read the full blog on Times Higher Education.
-
As I step out of the station, a drizzle is falling from the grey and cloudy sky. I wrap the thick black woollen scarf slightly tighter around my head. Having to cross the Sint Servaasbridge means being subject to the whims of winter winds which travel over the river Maas.
-
Dr. Aletta Jacobs is, in ieder geval voor de meeste Nederlanders, de belichaming van vrouwenrechten en gelijkheid. Maar hoeveel weet je nou écht van deze beroemde feministe? En waarom hebben we een onderwijsruimte naar deze vrouw vernoemd?
